Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lung.
BACKGROUND: The variable efficacy (0-80%) of Mycobacterium bovis Bacille Calmette Guréin (BCG) vaccine against adult tuberculosis (TB) necessitates development of alternative vaccine candidates. Development of recombinant BCG (rBCG) over-expressing promising immunodominant antigens of M. tuberculosi...
Main Authors: | Ruchi Jain, Bappaditya Dey, Neeraj Dhar, Vivek Rao, Ramandeep Singh, Umesh D Gupta, V M Katoch, V D Ramanathan, Anil K Tyagi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2008-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2586085?pdf=render |
Similar Items
-
A booster vaccine expressing a latency-associated antigen augments BCG induced immunity and confers enhanced protection against tuberculosis.
by: Bappaditya Dey, et al.
Published: (2011-01-01) -
Latency antigen α-crystallin based vaccination imparts a robust protection against TB by modulating the dynamics of pulmonary cytokines.
by: Bappaditya Dey, et al.
Published: (2011-01-01) -
Development of the first oligonucleotide microarray for global gene expression profiling in guinea pigs: defining the transcription signature of infectious diseases
by: Jain Ruchi, et al.
Published: (2012-10-01) -
Immunogenicity and Protective Efficacy of a Novel Recombinant BCG Strain Overexpressing Antigens Ag85A and Ag85B
by: Chun Wang, et al.
Published: (2012-01-01) -
Vaccination with a BCG strain overexpressing Ag85B protects cattle against Mycobacterium bovis challenge.
by: Caroline Rizzi, et al.
Published: (2012-01-01)